Methylthioninium chloride (INN, or methylene blue, proposed trade name Rember) is an investigational drug being developed by the University of Aberdeen and TauRx Therapeutics that has been shown in early clinical trials to be an inhibitor of Tau protein aggregation.
•
In vitro studies suggest that methylene blue might be an effective remedy for both Alzheimer's and Parkinson's disease by enhancing key mitochondrial biochemical pathways.
Polyvinyl chloride | polyvinyl chloride | Suxamethonium chloride | Potassium chloride | Gold chloride | Dicopper chloride trihydroxide | Chloride Electrical Storage Company | Tubocurarine chloride | Silver chloride electrode | potassium chloride | oxalyl chloride | Methanesulfonyl chloride | magnesium chloride | Congenital chloride diarrhea | Calcium chloride |